Subject(s)
Personality Disorders/etiology , Psychotic Disorders/etiology , Renal Dialysis/adverse effects , Uremia/therapy , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Infant , Interpersonal Relations , Male , Middle Aged , Peritoneal Dialysis/adverse effects , Peritoneal Dialysis, Continuous Ambulatory/adverse effectsSubject(s)
Cholecalciferol/therapeutic use , Chronic Kidney Disease-Mineral and Bone Disorder/drug therapy , Adult , Calcium/therapeutic use , Chronic Kidney Disease-Mineral and Bone Disorder/etiology , Dietary Proteins/therapeutic use , Energy Intake , Female , Humans , Male , Middle Aged , Renal Dialysis/adverse effects , Uremia/therapyABSTRACT
Chronic Renal Failure is a generalized functional impairment, due to Kidneys inability to maintain volume and composition of body fluids and solutes within normal conditions. In the attempt to point out the pathophysiology of Bright's syndrome, the Authors review the "intact nephron hypothesis" and his functional reserve. The uraemic clinical appearance is a very wide field of investigations and beside their own experience, the Authors present some datas and theories to explain the coming out and the evolution of poliuria and oliguria, hypertension, heart pathology, anemia and bleedings, hormonal and metabolic pathways alterations, calcium and bone diseases and central and peripheral uraemic neuropathy.
Subject(s)
Uremia/etiology , Anemia/etiology , Bone Diseases/etiology , Calcium/metabolism , Cardiac Output , Humans , Hypertension/complications , Kidney/physiopathology , Kidney Failure, Chronic/etiology , Nephrons/physiopathology , Nervous System Diseases/etiology , Prostaglandins/metabolismSubject(s)
Acute Kidney Injury/chemically induced , Kidney Tubular Necrosis, Acute/chemically induced , Rifampin/adverse effects , Adult , Female , Humans , Kidney/pathology , Kidney Tubular Necrosis, Acute/pathology , Male , Middle Aged , Respiratory Tract Infections/drug therapy , Rifampin/administration & dosage , Tuberculosis, Pulmonary/drug therapySubject(s)
Glomerular Filtration Rate , Pentetic Acid , Technetium , Adult , Diatrizoate , Female , Humans , Iodine Radioisotopes , Kidney Tubules/metabolism , Male , Middle Aged , Urinary CatheterizationSubject(s)
Blood Coagulation Disorders/drug therapy , Glomerulonephritis/drug therapy , Oxazoles/therapeutic use , Adolescent , Adult , Blood Coagulation Disorders/etiology , Child , Chronic Disease , Drug Evaluation , Female , Glomerulonephritis/complications , Humans , Male , Middle Aged , Oxazoles/administration & dosage , Oxazoles/adverse effects , Platelet Adhesiveness/drug effects , Platelet Aggregation/drug effects , Thromboembolism/prevention & controlSubject(s)
Brain Diseases/etiology , Cognition Disorders/etiology , Neural Conduction , Uremia/psychology , Adult , Brain Diseases/diagnostic imaging , Electroencephalography , Humans , Middle Aged , Psychological Tests , Renal Dialysis/adverse effects , Tomography, X-Ray Computed , Uremia/complications , Uremia/physiopathologyABSTRACT
The renal heamodynamic effects of a single i.v. administration of tolamolol were studied in 9 hypertensive subjects. No change of GFR and ERPF was observed after tolamolol, while urine output decreased and urine creatinine concentration increased. A reduction of the heart rate was confirmed. Blood pressure was unchanged.
